期刊文献+

三维适形放疗治疗非小细胞肺癌35例疗效观察

Clinical Analysis of 3-Dimensional Conformal Radiation Therapy for 35 Cases with Non-Small Cell Lung Cancer
下载PDF
导出
摘要 目的评价三维适形放射治疗肺癌的疗效。方法对35例肺癌采用三维适形放射治疗,其中男性19例,女性16例,年龄36~80岁,中位年龄66岁。设3~5个共面等中心照射野,80%-90%的等剂量线包绕PTV,靶区包括肿瘤边缘外0.5~1.5em,用6MVX线照射,总量为DT43.2~54Gy,2.25~3.6Cy/次,5次/周。放疗结束后1~2月复查CT。结果本组35例,CR5例(14.28%),PR20例(57.14%),SD9例(25.71%),PD1例(2.86%),有效率CR+PR为71.43%。结论三维适形放射治疗适用于肺癌的治疗,毒副反应小,效果明显。 Objective To evaluate the effects of three-dimensional conformal radiation therapy for lung carcinoma. Methods From August 2003 to July 2007 35 cases with lung carcinoma were treated with three-dimensional conformal. 19 were men, 16 were women, mean age 66, range from 36 to 80. Irradiation fielded had 3 -5, 80% -90% isodose line included PTV. The total radiation dose of 43.2 -54 Gy, 2.25 3.6 Gy/F, 5 F/W. For 3-DCRT, radiation was given by 6 MV-X. Results In all the patients, the overall response rate was 71.43 %. There were 5(14.28% ) complete response (CR), 20(57.14% ) partial response (PR), 9(25.71% ) stable response (SD), 1(2.86% ) progressive response (PD). Conclusion 3-DCRT was feasible in the treatment of lung carcinoma, with good immediate tumor response, and milder toxicity.
出处 《肿瘤基础与临床》 2008年第4期330-331,共2页 journal of basic and clinical oncology
关键词 非小细胞肺癌 三维适形放疗 疗效 non-small cell lung cancer three-dimensional conformal radiation therapy curative effect
  • 相关文献

参考文献6

二级参考文献49

  • 1于金明,郭守芳,李万湖,黄勇,尹莉萍,付政,李文武.非小细胞肺癌术前肺门纵隔淋巴结CT检查和术后病理结果比较的研究[J].肿瘤防治杂志,2003,10(12):1287-1289. 被引量:11
  • 2黎庶,马述盛,王天君,张景荣,赵惠儒,傅志民.CT诊断肺癌纵隔淋巴结转移判定标准的研究[J].中国医科大学学报,1995,24(2):193-195. 被引量:2
  • 3Salminen E, Mac Manus M. FDG-PET imaging in the management of non-small-cell lung cancer. Ann Oncol, 2002,13: 357-360.
  • 4Rohren EM, Lowe VJ. Update in PET imaging of nonsmall cell lung cancer. Semin Nucl Med, 2004,34:134-153.
  • 5Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys,2001,51:923-931.
  • 6Nestle U, Walter K, Schmidt S,et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer:high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys,1999,44:593-597.
  • 7Erdi YE,Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol,2002,62:51-60.
  • 8Balogh JB, Caldwell CB, Ung YC, et al. Interobserver variation in contouring gross tumor volume in carcinoma of the lung associated with pneumonitis and atelectasis:the impact of 18FDG-hybrid pet fusion. Int J Radiat Oncol Biol Phys,2000,48:128-129.
  • 9Chapman JD, Bradley JD, Eary JF, et al. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys, 2003,55: 294-301.
  • 10Martel MK, Ten Haten RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small-cell lung cancer patients. Lung Cancer, 1999, 24:31-37.

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部